The Global Cancer Stem Cells Market size is estimated to reach USD 2.18 Billion from USD 917.5 Million in 2019, delivering a growth rate of 11% through 2027, according to a new report by Reports and Data. The demand for cancer stem cell markers is exponentially growing on account of growing public awareness regarding the therapeutic strength of products, public-private investments in drug development, and the development of a regulatory framework for cancer stem cell therapeutics.
The treatment of cancer can damage the hematopoietic stem cells in the body. The hematopoietic stem cells are stem cells that turn into blood cells. Stem cell transplant helps with blood-forming stem cells in patients that have undergone a high dosage of radiation or chemotherapy and have damaged stem cells as a reaction. Embryonic stem cells are the main source of stem cells for therapeutic purposes due to high potency and their indefinite lifespan. The growing prevalence of the deadly disease will supplement the market share over the forecast period. According to the World Health Organization, there were nearly 18.1 million new cancer cases and 9.6 million deaths in 2018. Cancer Research UK has predicted there will be 27.5 million new cases each year globally by 2040.
The increasing morbidity and mortality rates of cancer have led to rising funding from the government along with growth in many research activities to develop stem cell therapies. Several industry players are supported by government funding for the development of these therapies. For instance, Stemcell Technologies, the biggest biotechnology firm, accepted USD 45 million from a joint venture of British Columbia and the Government of Canada in April 2018 for the expansion of technologies to assist clinical trials in the field of tissue engineering, cell therapy, immunotherapy, reformative medicine, and gene therapy to treat cancer and other diseases. These strategies by the industry players will bolster the industry growth through 2027.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3047
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
AbbVie, Inc., Bionomics, Thermo Fisher Scientific, Inc., Merck KGaA, LONZA, Miltenyi Biotec, Stemline Therapeutics, Inc., PromoCell GmbH, Irvine Scientific, and MacroGenics, Inc
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3047
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Cancer Stem Cells market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Cancer Stem Cells industry, the market is segmented into:
Treatment Type Outlook (Revenue, USD Billion; 2017-2027)
- Allogeneic Stem Cell Transplants
- Autologous Stem Cell Transplants
- Syngeneic Stem Cell Transplants
Disease Type Outlook (Revenue, USD Billion; 2017-2027)
- Blood Cancer
- Lung Cancer
- Breast Cancer
- Brain Cancer
- Liver Cancer
- Colorectal Cancer
- Bladder Cancer
- Pancreatic Cancer
- Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals and Surgical Centers
- Cell Banks and Tissue Banks
- Academic Institutes, Research Laboratories, and CROs
- Pharmaceutical and Biotech Companies
The regional analysis covers:
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/cancer-stem-cells-market
Benefits of Cancer Stem Cells Market Report:
- Panoramic overview of the opportunities and risks in the Cancer Stem Cells sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Cancer Stem Cells industry
- In-depth assessment of the competitive landscape of the key players of the Cancer Stem Cells industry
- Analysis of the Cancer Stem Cells market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3047
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Peritoneal Dialysis Market Report
